Kabra Drugs Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh)
Kabra Drugs Ltd · Financial Result · 07 Nov 2026, 12:46 am
Kabra Drugs Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Lakh) ■ Revenue: 3,195 (+61.7% YoY | -30.9% QoQ) ■ EBITDA: 269 (+31.9% YoY | -3.6% QoQ) ■ EBITDA Margin (%): 8.4 (-190 bps YoY | +238 bps QoQ) ■ PAT: 192 (+4.6% YoY | -9.5% QoQ) ■ EPS (INR): 0.81 (+5.2% YoY | -10.0% QoQ)
Original exchange filing (PDF)
More announcements from Kabra Drugs Ltd
- Undertaking for Non-Applicability of Regulation 32 of SEBI (LODR) · 07 Nov 2026
- Kabra Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting to .... · 06 Nov 2026
- Scrutinizers Report · 01 Oct 2026
- Proceedings of Annual General Meeting · 30 Sept 2026
- Reg. 34 (1) of Annual Report for the financial year 2025-2026 · 09 Sept 2026
- Notice 37th Annual General Meeting of the Company · 08 Sept 2026
- Appointment of Internal Auditor of the Company · 03 Sept 2026
- Appointment of Secretarial Auditor of the Company · 03 Sept 2026
